Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors

Hypertonic saline (HS) inhalation therapy benefits cystic fibrosis (CF) patients [Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006; Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT; the National Hyperto...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American Journal of Physiology: Cell Physiology 2013-12, Vol.305 (11), p.C1114-C1122
Hauptverfasser: Rasgado-Flores, Hector, Krishna Mandava, Vamsi, Siman, Homayoun, Van Driessche, Willy, Pilewski, Joseph M, Randell, Scott H, Bridges, Robert J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page C1122
container_issue 11
container_start_page C1114
container_title American Journal of Physiology: Cell Physiology
container_volume 305
creator Rasgado-Flores, Hector
Krishna Mandava, Vamsi
Siman, Homayoun
Van Driessche, Willy
Pilewski, Joseph M
Randell, Scott H
Bridges, Robert J
description Hypertonic saline (HS) inhalation therapy benefits cystic fibrosis (CF) patients [Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006; Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT; the National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group. N Engl J Med 354: 229-240, 2006]. Surprisingly, these benefits are long-lasting and are diminished by the epithelial Na(+) channel blocker amiloride (Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006). Our aim was to explain these effects. Human bronchial epithelial (hBE) cells from CF lungs were grown in inserts and were used in three experimental approaches: 1) Ussing chambers to measure amiloride-sensitive short-circuit currents (INa); 2) continuous perfusion Ussing chambers; and 3) near "thin-film" conditions in which the airway surface of the inserts was exposed to a small volume (30 μl) of isosmotic or HS solution as the inserts were kept in their incubation tray and were subsequently used to measure INa under isosmotic conditions (near thin-film experiments; Tarran R, Boucher RC. Methods Mol Med 70: 479-492, 2002). HS solutions (660 mosmol/kgH2O) were prepared by adding additional NaCl to the isosmotic buffer. The transepithelial short-circuit current (ISC), conductance (GT), and capacitance (CT) were measured by transepithelial impedance analysis (Danahay H, Atherton HC, Jackson AD, Kreindler JL, Poll CT, Bridges RJ. Am J Physiol Lung Cell Mol Physiol 290: L558-L569, 2006; Singh AK, Singh S, Devor DC, Frizzell RA, van Driessche W, Bridges RJ. Methods Mol Med 70: 129-142, 2002). Exposure to apical HS inhibited INa, GT, and CT. The INa inhibition required 60 min of reexposure to the isosmotic solution to recover 75%. The time of exposure to HS required to inhibit INa was
doi_str_mv 10.1152/ajpcell.00166.2013
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3882386</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3158648091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-d334e8ac3e54db88825beaafd0aba005fddba419fa1a5f3b391c7136ee35a6163</originalsourceid><addsrcrecordid>eNpdkc1u1TAQhS0EopfCC7BAltiwycXOOL7JBglV5UeqxAbW1sQ_ja8SO9gJ0n2LPjIOva2AlS3NN2fmzCHkNWd7zpv6PR5nbcdxzxiXcl8zDk_IrhTqijcSnpIdAwmV5AIuyIucj4wxUcvuObmooWsl7w47cnftnNULjY7i7DWOdDjNNsU8xcVrmqPx60T1gONow62lGAzFyY8xeWNpDA_EkjDkOaaF-kCHdcJA-xSDHnyRtLNfBjtu323hTF2KRfSUtxHOFzD7TE0MMeWX5JnDMdtX5_eS_Ph0_f3qS3Xz7fPXq483lRbAlsoACNuiBtsI07dtWze9RXSGYY-MNc6YHgXvHHJsHPTQcX3gIK2FBiWXcEk-3OvOaz9Zo20oFkY1Jz9hOqmIXv1bCX5Qt_GXgjIL2k3g3VkgxZ-rzYuafN7sYbBxzYoLKUR3AMEL-vY_9BjXFIq9jWoPvO5aKFR9T-lyj5yse1yGM7UFrs6Bqz-Bqy3w0vTmbxuPLQ8Jw2-OMa3F</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1468712983</pqid></control><display><type>article</type><title>Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors</title><source>MEDLINE</source><source>American Physiological Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Rasgado-Flores, Hector ; Krishna Mandava, Vamsi ; Siman, Homayoun ; Van Driessche, Willy ; Pilewski, Joseph M ; Randell, Scott H ; Bridges, Robert J</creator><creatorcontrib>Rasgado-Flores, Hector ; Krishna Mandava, Vamsi ; Siman, Homayoun ; Van Driessche, Willy ; Pilewski, Joseph M ; Randell, Scott H ; Bridges, Robert J</creatorcontrib><description>Hypertonic saline (HS) inhalation therapy benefits cystic fibrosis (CF) patients [Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006; Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT; the National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group. N Engl J Med 354: 229-240, 2006]. Surprisingly, these benefits are long-lasting and are diminished by the epithelial Na(+) channel blocker amiloride (Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006). Our aim was to explain these effects. Human bronchial epithelial (hBE) cells from CF lungs were grown in inserts and were used in three experimental approaches: 1) Ussing chambers to measure amiloride-sensitive short-circuit currents (INa); 2) continuous perfusion Ussing chambers; and 3) near "thin-film" conditions in which the airway surface of the inserts was exposed to a small volume (30 μl) of isosmotic or HS solution as the inserts were kept in their incubation tray and were subsequently used to measure INa under isosmotic conditions (near thin-film experiments; Tarran R, Boucher RC. Methods Mol Med 70: 479-492, 2002). HS solutions (660 mosmol/kgH2O) were prepared by adding additional NaCl to the isosmotic buffer. The transepithelial short-circuit current (ISC), conductance (GT), and capacitance (CT) were measured by transepithelial impedance analysis (Danahay H, Atherton HC, Jackson AD, Kreindler JL, Poll CT, Bridges RJ. Am J Physiol Lung Cell Mol Physiol 290: L558-L569, 2006; Singh AK, Singh S, Devor DC, Frizzell RA, van Driessche W, Bridges RJ. Methods Mol Med 70: 129-142, 2002). Exposure to apical HS inhibited INa, GT, and CT. The INa inhibition required 60 min of reexposure to the isosmotic solution to recover 75%. The time of exposure to HS required to inhibit INa was &lt;2.5 min. Under near thin-film conditions, apical exposure to HS inhibited INa, but as osmotically driven water moved to the apical surface, the aqueous apical volume increased, leading to an amiloride-insensitive decrease in its osmolality and to recovery of INa that lagged behind the osmotic recovery. Amiloride significantly accelerated the recovery of INa following exposure to HS. Our conclusions are that exposure to HS inhibits hBE INa and that amiloride diminishes this effect.</description><identifier>ISSN: 0363-6143</identifier><identifier>EISSN: 1522-1563</identifier><identifier>DOI: 10.1152/ajpcell.00166.2013</identifier><identifier>PMID: 23986197</identifier><identifier>CODEN: AJPCDD</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Airway management ; Amiloride - administration &amp; dosage ; Bronchi - drug effects ; Bronchi - metabolism ; Bronchi - pathology ; Cell Culture Techniques - methods ; Cells ; Cells, Cultured ; Cystic fibrosis ; Cystic Fibrosis - drug therapy ; Cystic Fibrosis - metabolism ; Humans ; Ion Transport - drug effects ; Ion Transport - physiology ; Lungs ; Osmosis ; Respiratory Mucosa - drug effects ; Respiratory Mucosa - metabolism ; Respiratory Mucosa - pathology ; Saline Solution, Hypertonic - administration &amp; dosage ; Sodium - metabolism ; Thin films</subject><ispartof>American Journal of Physiology: Cell Physiology, 2013-12, Vol.305 (11), p.C1114-C1122</ispartof><rights>Copyright American Physiological Society Dec 1, 2013</rights><rights>Copyright © 2013 the American Physiological Society 2013 American Physiological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-d334e8ac3e54db88825beaafd0aba005fddba419fa1a5f3b391c7136ee35a6163</citedby><cites>FETCH-LOGICAL-c430t-d334e8ac3e54db88825beaafd0aba005fddba419fa1a5f3b391c7136ee35a6163</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,781,785,886,3040,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23986197$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rasgado-Flores, Hector</creatorcontrib><creatorcontrib>Krishna Mandava, Vamsi</creatorcontrib><creatorcontrib>Siman, Homayoun</creatorcontrib><creatorcontrib>Van Driessche, Willy</creatorcontrib><creatorcontrib>Pilewski, Joseph M</creatorcontrib><creatorcontrib>Randell, Scott H</creatorcontrib><creatorcontrib>Bridges, Robert J</creatorcontrib><title>Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors</title><title>American Journal of Physiology: Cell Physiology</title><addtitle>Am J Physiol Cell Physiol</addtitle><description>Hypertonic saline (HS) inhalation therapy benefits cystic fibrosis (CF) patients [Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006; Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT; the National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group. N Engl J Med 354: 229-240, 2006]. Surprisingly, these benefits are long-lasting and are diminished by the epithelial Na(+) channel blocker amiloride (Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006). Our aim was to explain these effects. Human bronchial epithelial (hBE) cells from CF lungs were grown in inserts and were used in three experimental approaches: 1) Ussing chambers to measure amiloride-sensitive short-circuit currents (INa); 2) continuous perfusion Ussing chambers; and 3) near "thin-film" conditions in which the airway surface of the inserts was exposed to a small volume (30 μl) of isosmotic or HS solution as the inserts were kept in their incubation tray and were subsequently used to measure INa under isosmotic conditions (near thin-film experiments; Tarran R, Boucher RC. Methods Mol Med 70: 479-492, 2002). HS solutions (660 mosmol/kgH2O) were prepared by adding additional NaCl to the isosmotic buffer. The transepithelial short-circuit current (ISC), conductance (GT), and capacitance (CT) were measured by transepithelial impedance analysis (Danahay H, Atherton HC, Jackson AD, Kreindler JL, Poll CT, Bridges RJ. Am J Physiol Lung Cell Mol Physiol 290: L558-L569, 2006; Singh AK, Singh S, Devor DC, Frizzell RA, van Driessche W, Bridges RJ. Methods Mol Med 70: 129-142, 2002). Exposure to apical HS inhibited INa, GT, and CT. The INa inhibition required 60 min of reexposure to the isosmotic solution to recover 75%. The time of exposure to HS required to inhibit INa was &lt;2.5 min. Under near thin-film conditions, apical exposure to HS inhibited INa, but as osmotically driven water moved to the apical surface, the aqueous apical volume increased, leading to an amiloride-insensitive decrease in its osmolality and to recovery of INa that lagged behind the osmotic recovery. Amiloride significantly accelerated the recovery of INa following exposure to HS. Our conclusions are that exposure to HS inhibits hBE INa and that amiloride diminishes this effect.</description><subject>Airway management</subject><subject>Amiloride - administration &amp; dosage</subject><subject>Bronchi - drug effects</subject><subject>Bronchi - metabolism</subject><subject>Bronchi - pathology</subject><subject>Cell Culture Techniques - methods</subject><subject>Cells</subject><subject>Cells, Cultured</subject><subject>Cystic fibrosis</subject><subject>Cystic Fibrosis - drug therapy</subject><subject>Cystic Fibrosis - metabolism</subject><subject>Humans</subject><subject>Ion Transport - drug effects</subject><subject>Ion Transport - physiology</subject><subject>Lungs</subject><subject>Osmosis</subject><subject>Respiratory Mucosa - drug effects</subject><subject>Respiratory Mucosa - metabolism</subject><subject>Respiratory Mucosa - pathology</subject><subject>Saline Solution, Hypertonic - administration &amp; dosage</subject><subject>Sodium - metabolism</subject><subject>Thin films</subject><issn>0363-6143</issn><issn>1522-1563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkc1u1TAQhS0EopfCC7BAltiwycXOOL7JBglV5UeqxAbW1sQ_ja8SO9gJ0n2LPjIOva2AlS3NN2fmzCHkNWd7zpv6PR5nbcdxzxiXcl8zDk_IrhTqijcSnpIdAwmV5AIuyIucj4wxUcvuObmooWsl7w47cnftnNULjY7i7DWOdDjNNsU8xcVrmqPx60T1gONow62lGAzFyY8xeWNpDA_EkjDkOaaF-kCHdcJA-xSDHnyRtLNfBjtu323hTF2KRfSUtxHOFzD7TE0MMeWX5JnDMdtX5_eS_Ph0_f3qS3Xz7fPXq483lRbAlsoACNuiBtsI07dtWze9RXSGYY-MNc6YHgXvHHJsHPTQcX3gIK2FBiWXcEk-3OvOaz9Zo20oFkY1Jz9hOqmIXv1bCX5Qt_GXgjIL2k3g3VkgxZ-rzYuafN7sYbBxzYoLKUR3AMEL-vY_9BjXFIq9jWoPvO5aKFR9T-lyj5yse1yGM7UFrs6Bqz-Bqy3w0vTmbxuPLQ8Jw2-OMa3F</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>Rasgado-Flores, Hector</creator><creator>Krishna Mandava, Vamsi</creator><creator>Siman, Homayoun</creator><creator>Van Driessche, Willy</creator><creator>Pilewski, Joseph M</creator><creator>Randell, Scott H</creator><creator>Bridges, Robert J</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20131201</creationdate><title>Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors</title><author>Rasgado-Flores, Hector ; Krishna Mandava, Vamsi ; Siman, Homayoun ; Van Driessche, Willy ; Pilewski, Joseph M ; Randell, Scott H ; Bridges, Robert J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-d334e8ac3e54db88825beaafd0aba005fddba419fa1a5f3b391c7136ee35a6163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Airway management</topic><topic>Amiloride - administration &amp; dosage</topic><topic>Bronchi - drug effects</topic><topic>Bronchi - metabolism</topic><topic>Bronchi - pathology</topic><topic>Cell Culture Techniques - methods</topic><topic>Cells</topic><topic>Cells, Cultured</topic><topic>Cystic fibrosis</topic><topic>Cystic Fibrosis - drug therapy</topic><topic>Cystic Fibrosis - metabolism</topic><topic>Humans</topic><topic>Ion Transport - drug effects</topic><topic>Ion Transport - physiology</topic><topic>Lungs</topic><topic>Osmosis</topic><topic>Respiratory Mucosa - drug effects</topic><topic>Respiratory Mucosa - metabolism</topic><topic>Respiratory Mucosa - pathology</topic><topic>Saline Solution, Hypertonic - administration &amp; dosage</topic><topic>Sodium - metabolism</topic><topic>Thin films</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rasgado-Flores, Hector</creatorcontrib><creatorcontrib>Krishna Mandava, Vamsi</creatorcontrib><creatorcontrib>Siman, Homayoun</creatorcontrib><creatorcontrib>Van Driessche, Willy</creatorcontrib><creatorcontrib>Pilewski, Joseph M</creatorcontrib><creatorcontrib>Randell, Scott H</creatorcontrib><creatorcontrib>Bridges, Robert J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Physical Education Index</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American Journal of Physiology: Cell Physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rasgado-Flores, Hector</au><au>Krishna Mandava, Vamsi</au><au>Siman, Homayoun</au><au>Van Driessche, Willy</au><au>Pilewski, Joseph M</au><au>Randell, Scott H</au><au>Bridges, Robert J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors</atitle><jtitle>American Journal of Physiology: Cell Physiology</jtitle><addtitle>Am J Physiol Cell Physiol</addtitle><date>2013-12-01</date><risdate>2013</risdate><volume>305</volume><issue>11</issue><spage>C1114</spage><epage>C1122</epage><pages>C1114-C1122</pages><issn>0363-6143</issn><eissn>1522-1563</eissn><coden>AJPCDD</coden><abstract>Hypertonic saline (HS) inhalation therapy benefits cystic fibrosis (CF) patients [Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006; Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT; the National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group. N Engl J Med 354: 229-240, 2006]. Surprisingly, these benefits are long-lasting and are diminished by the epithelial Na(+) channel blocker amiloride (Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006). Our aim was to explain these effects. Human bronchial epithelial (hBE) cells from CF lungs were grown in inserts and were used in three experimental approaches: 1) Ussing chambers to measure amiloride-sensitive short-circuit currents (INa); 2) continuous perfusion Ussing chambers; and 3) near "thin-film" conditions in which the airway surface of the inserts was exposed to a small volume (30 μl) of isosmotic or HS solution as the inserts were kept in their incubation tray and were subsequently used to measure INa under isosmotic conditions (near thin-film experiments; Tarran R, Boucher RC. Methods Mol Med 70: 479-492, 2002). HS solutions (660 mosmol/kgH2O) were prepared by adding additional NaCl to the isosmotic buffer. The transepithelial short-circuit current (ISC), conductance (GT), and capacitance (CT) were measured by transepithelial impedance analysis (Danahay H, Atherton HC, Jackson AD, Kreindler JL, Poll CT, Bridges RJ. Am J Physiol Lung Cell Mol Physiol 290: L558-L569, 2006; Singh AK, Singh S, Devor DC, Frizzell RA, van Driessche W, Bridges RJ. Methods Mol Med 70: 129-142, 2002). Exposure to apical HS inhibited INa, GT, and CT. The INa inhibition required 60 min of reexposure to the isosmotic solution to recover 75%. The time of exposure to HS required to inhibit INa was &lt;2.5 min. Under near thin-film conditions, apical exposure to HS inhibited INa, but as osmotically driven water moved to the apical surface, the aqueous apical volume increased, leading to an amiloride-insensitive decrease in its osmolality and to recovery of INa that lagged behind the osmotic recovery. Amiloride significantly accelerated the recovery of INa following exposure to HS. Our conclusions are that exposure to HS inhibits hBE INa and that amiloride diminishes this effect.</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>23986197</pmid><doi>10.1152/ajpcell.00166.2013</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0363-6143
ispartof American Journal of Physiology: Cell Physiology, 2013-12, Vol.305 (11), p.C1114-C1122
issn 0363-6143
1522-1563
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3882386
source MEDLINE; American Physiological Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Airway management
Amiloride - administration & dosage
Bronchi - drug effects
Bronchi - metabolism
Bronchi - pathology
Cell Culture Techniques - methods
Cells
Cells, Cultured
Cystic fibrosis
Cystic Fibrosis - drug therapy
Cystic Fibrosis - metabolism
Humans
Ion Transport - drug effects
Ion Transport - physiology
Lungs
Osmosis
Respiratory Mucosa - drug effects
Respiratory Mucosa - metabolism
Respiratory Mucosa - pathology
Saline Solution, Hypertonic - administration & dosage
Sodium - metabolism
Thin films
title Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T17%3A51%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20apical%20hyperosmotic%20sodium%20challenge%20and%20amiloride%20on%20sodium%20transport%20in%20human%20bronchial%20epithelial%20cells%20from%20cystic%20fibrosis%20donors&rft.jtitle=American%20Journal%20of%20Physiology:%20Cell%20Physiology&rft.au=Rasgado-Flores,%20Hector&rft.date=2013-12-01&rft.volume=305&rft.issue=11&rft.spage=C1114&rft.epage=C1122&rft.pages=C1114-C1122&rft.issn=0363-6143&rft.eissn=1522-1563&rft.coden=AJPCDD&rft_id=info:doi/10.1152/ajpcell.00166.2013&rft_dat=%3Cproquest_pubme%3E3158648091%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1468712983&rft_id=info:pmid/23986197&rfr_iscdi=true